Genomic approach to evaluate the intrinsic antibacterial activity of novel diazabicyclooctanes (zidebactam and nacubactam) against clinical Escherichia coli isolates from diverse clonal lineages in the United Arab Emirates
Journal of Infection and Public Health · 2025
DOI: 10.1016/j.jiph.2025.102761 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Infection and Public Health, 2025. Verfasst von Farah Al-Marzooq und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emir…. Hauptthemen laut MEDLINE: Escherichia coli, Azabicyclo Compounds, Anti-Bacterial Agents, Escherichia coli Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United Arab Emirates University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates. Electronic address: f.almarzooq@uaeu.ac.ae.
- Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.
- Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates; Tawam Hospital, Al-Ain, United Arab Emirates.
- Tawam Hospital, Al-Ain, United Arab Emirates.
- Burjeel Medical City/coLAB, Abu Dhabi, United Arab Emirates.
Förderung
- United Arab Emirates University
Zitieren
APA
Al-Marzooq, F., Ghazawi, A., Alshamsi, M., Alzaabi, A., Aleissaee, O., Almansoori, H., Alsaadi, A., Aldhaheri, R., Ahli, H., Daoud, L., Ahmad, A., Collyns, T., & Oommen, S. (2025). Genomic approach to evaluate the intrinsic antibacterial activity of novel diazabicyclooctanes (zidebactam and nacubactam) against clinical Escherichia coli isolates from diverse clonal lineages in the United Arab Emirates. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2025.102761
Vancouver
Al-Marzooq F, Ghazawi A, Alshamsi M, Alzaabi A, Aleissaee O, Almansoori H, et al. Genomic approach to evaluate the intrinsic antibacterial activity of novel diazabicyclooctanes (zidebactam and nacubactam) against clinical Escherichia coli isolates from diverse clonal lineages in the United Arab Emirates. Journal of Infection and Public Health. 2025. doi:10.1016/j.jiph.2025.102761
BibTeX
@article{AlMarzooq2025,
author = {Al-Marzooq, Farah and Ghazawi, Akela and Alshamsi, Maitha and Alzaabi, Abdulrahman and Aleissaee, Omar and Almansoori, Hamad and Alsaadi, Abdullah and Aldhaheri, Rauda and Ahli, Hafsa and Daoud, Lana and Ahmad, Amna and Collyns, Timothy and Oommen, Seema},
title = {Genomic approach to evaluate the intrinsic antibacterial activity of novel diazabicyclooctanes (zidebactam and nacubactam) against clinical Escherichia coli isolates from diverse clonal lineages in the United Arab Emirates},
journal = {Journal of Infection and Public Health},
year = {2025},
doi = {10.1016/j.jiph.2025.102761}
}
EUVIMED